Global Monkeypox Diagnostics Market Analysis & Forecasts 2022-2024 and 2026: Multiplex Opportunity, Dx Moves ...
DUBLIN, Feb. 28, 2024 /PRNewswire/ -- The "Global Monkeypox Diagnostics Market by Assay, Country, Product, and Place, with Executive & Consultant Guides and Market Analysis & Forecasts 2022-2026" report has been added to ResearchAndMarkets.com's offering.
This report forecasts the market size out to 2026.
Monkeypox is being declared a health emergency. The latest data shows the outbreak into non-African regions is expanding at alarming rates. Governments around the world are preparing to use widespread testing to get in front of this threat from the beginning. Opportunities are abound for the In Vitro Diagnostic industry.
Growth is coming from basic factors but the COVID-19 pandemic has changed the market landscape now and for the foreseeable future. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnostics and the Genomics Revolution are merging to create new diagnostic opportunities.
Scope of the Report
Monkeypox Global Diagnostic Markets Overview
- Monkeypox Diagnostics - Global Market Overview by Country
- Global Monkeypox Diagnostics Markets Overview by Assay
- Global Monkeypox Diagnostics Markets Overview by Product
- Global Monkeypox Diagnostics Markets Overview by Place
Monkeypox Diagnostic Market - by Assay
- Monkeypox Diagnostic - PCR
- Monkeypox Diagnostic - NGS
- Monkeypox Diagnostic - Rapid
- Monkeypox Diagnostic - Other Assay
- Monkeypox Diagnostic - Biomarker Other
Global Monkeypox Diagnostics Markets - By Product
- Monkeypox Diagnostic - Instrumentation
- Monkeypox Diagnostic - Consumables
- Monkeypox Diagnostic - Software & Service
Global Monkeypox Diagnostics Markets - By Place
- Monkeypox Diagnostic - Hospital
- Monkeypox Diagnostic - Clinic/POL
- Monkeypox Diagnostic - Other Place
Key Topics Covered:
1 Market Guides1.1 Situation Analysis1.2 Guide for Executives and Marketing Staff1.3 Guide for Investment Analysts and Management Consultants
2 Introduction and Market Definition2.1 An Overview of Monkeypox Diagnostics2.1.1 The 2022 Outbreak2.2 Market Definition2.2.1 Market Size2.2.2 Currency2.2.3 Years2.2.4 PCR2.2.5 NGS2.2.6 Syndromic PoC2.2.7 Biomarkers Molecular Diagnostics2.2.8 Biomarkers Other2.2.9 Limitations2.3 Methodology2.3.1 Methodology2.4 Healthcare and the IVD Industry2.4.1 Global Healthcare Spending2.4.2 Spending on Diagnostics2.4.3 Important Role of Insurance for Diagnostics
3 Monkeypox - Current Science3.1 What is Monkeypox?3.2 Outbreaks3.3 Transmission3.4 Signs and symptoms3.5 Diagnosis3.6 Therapeutics3.6.1 Vaccination3.6.2 Prevention3.6.2.1 Reducing the risk of human-to-human transmission3.6.2.2 Reducing the risk of zoonotic transmission3.7 How Monkeypox relates to smallpox
4 Industry Overview4.1 Players in a Dynamic Market4.1.1 Academic Research Lab4.1.2 Diagnostic Test Developer4.1.3 Pharmaceutical/Reagent Supplier4.1.4 Independent Testing Lab4.1.5 Public National/regional lab4.1.6 Hospital lab4.1.7 Physician Lab4.1.8 Audit Body4.1.9 Certification Body
5 Market Trends5.1 Factors Driving Growth5.1.1 Prevalence5.1.2 Surveillance5.1.3 Pandemic Wind Down5.1.4 Viral Zeitqeist5.2 Factors Limiting Growth5.2.1 The Cost Curve Shrinks the Market5.2.2 Transmission Outlook5.2.3 Adoption Lag and Cost Control5.3 Diagnostic Technology Development5.3.1 The Multiplex Opportunity5.3.2 Shifting Role of Physicians in Diagnosis5.3.3 Diagnostics Moves Out of the Lab5.3.4 Biomarkers and Algorithms5.3.5 Rapid Testing Changing Medical Practice5.3.6 Genome Role and Big Data
6 Monkeypox Diagnostics - Recent Developments6.1 Recent Developments - Importance and How to Use This Section6.1.1 Importance of These Developments6.1.2 How to Use This Section6.2 U.S. to declare Monkeypox a public health emergency6.3 BioGX Gets CE-IVD Mark for Multigene POC Test6.4 World Health Organization declares Monkeypox a global emergency6.5 Quest Begins Offering Internally Developed Monkeypox Test6.6 CDC, Abbott, Roche, BioMerieux Get FDA 510(k) Clearances6.7 Commercial, Academic Labs Ramp Up Monkeypox Testing6.8 Becton Dickinson, CerTest Biotec Collaborate on Monkeypox MDx6.9 Sequence Coming In
7 Profiles of Key Companies7.1 Abbott Diagnostics7.2 Aegis Laboratories7.3 Applied DNA Sciences7.4 Beckman Coulter Diagnostics7.5 Becton, Dickinson and Company7.6 BioGX7.7 bioMerieux Diagnostics7.8 Bio-Rad Laboratories, Inc.7.9 Cepheid7.10 CerTest Biotec7.11 Creative Biogene7.12 Flow Health7.13 Labcorp7.14 Mayo Clinic Laboratories7.15 Quest Diagnostics7.16 Qiagen Gmbh7.17 Roche Molecular Diagnostics7.18 Siemens Healthineers7.19 Sonic Healthcare7.20 Sysmex7.21 Thermo Fisher Scientific Inc.
Appendices: United States Medicare System: 2022 Clinical Laboratory Fees Schedule
For more information about this report visit https://www.researchandmarkets.com/r/ppt3lw
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and MarketsLaura Wood, Senior Manager[email protected] For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets